NSPR Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 apr 2024 @ 22:00):

Stats
Dagens volum	10 238.00
Gjennomsnittsvolum	34 706.00
Markedsverdi	46.80M
EPS	$0 ( 2024-04-04 )
Neste inntjeningsdato	( $-0.150 ) 2024-05-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.44
ATR14	$0.0220 (1.10%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-23	Kester Thomas J	Buy	29 032	Common Stock
2024-01-23	Kester Thomas J	Buy	11 098	Options to purchase common stock (right to buy)
2024-01-23	Verta Patrick	Buy	85 720	Common Stock
2024-01-23	Verta Patrick	Buy	32 768	Options to purchase common stock (right to buy)
2024-01-23	Gleason Shane Thomas	Buy	238 625	Common Stock

INSIDER POWER
98.06
Last 99 transactions
Buy: 7 620 190 \| Sell: 72 371

InspireMD Inc Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

InspireMD Inc Økonomi

Annual	2023
Omsetning:	$6.21M
Bruttogevinst:	$1.81M (29.12 %)
EPS:	$-0.820

FY	2023
Omsetning:	$6.21M
Bruttogevinst:	$1.81M (29.12 %)
EPS:	$-0.820

FY	2022
Omsetning:	$5.17M
Bruttogevinst:	$1.12M (21.60 %)
EPS:	$-2.35

FY	2021
Omsetning:	$4.50M
Bruttogevinst:	$754 000 (16.77 %)
EPS:	$-2.03

Financial Reports:

No articles found.

InspireMD Inc

InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions, as well as bypass surgery. It is also developing PVGuard, a MicroNet mesh sleeve and self-expandable stent for use in peripheral vascular applications. The company sells its products through local distributors. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.